ClinicalTrials.Veeva

Menu

Management of Myopia in University Students Using Dual Focus Soft Contact Lenses (MoMUS)

U

University of Bradford

Status

Invitation-only

Conditions

Myopia, Progressive

Treatments

Device: MiSight contact lenses
Device: Proclear contact lenses

Study type

Interventional

Funder types

Other
Industry

Identifiers

Details and patient eligibility

About

The purpose of the study is to quantify the effectiveness of Coopervision MiSight contact lenses in slowing the rate of myopia progression in university students.

Full description

MiSight contact lenses have been shown to be a safe and effective way of managing myopia progression in children aged 8-12 years. However, myopic progression is not limited to children of this age group and MiSight lenses have also been shown to be effective in older children aged 11-16 years. There is evidence that progression also occurs in university students. The researchers are therefore investigating the effectiveness of this intervention in a group of UK-based University students.

Enrollment

84 estimated patients

Sex

All

Ages

18 to 21 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Be a myopic students studying at university
  • Be aged 18-21 years at the start of the study
  • Show evidence of recent myopia progression prior to commencement of Stage 2 of the study.
  • Have read the patient information sheet and be happy to sign the consent forms
  • Be willing to adhere to the visit schedule and wearing times described in this protocol
  • Agree to lens wearing times of at least 10 hours per day, 6 days per week
  • Agree to accept either the control or test lens as assigned by the randomisation
  • Have BCVA of +0.10 logMAR or better in each eye

Exclusion criteria

  • Previous myopia control use (optical or pharmacological)
  • Amblyopia
  • Ocular pathology such as keratoconus or recurrent corneal infections
  • Myopic Rx > 10D
  • Astigmatism >1D
  • Anisometropia >1.75D
  • Binocular Vision anomalies (such as Tropia)
  • Medications that affect pupil size or accommodation
  • A known allergy to fluorescein or tropicamide
  • Biomicroscopic findings that would contraindicate contact lens wear
  • The investigator considers that it is not in the best interest of the subject to participate in the study.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

84 participants in 2 patient groups

MiSight dual focus contact lens
Experimental group
Treatment:
Device: MiSight contact lenses
Proclear single vision contact lens
Active Comparator group
Treatment:
Device: Proclear contact lenses

Trial contacts and locations

2

Loading...

Central trial contact

Martin Brinkworth, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems